王伊龙,男,医学博士,主任医师,教授,享受国务院政府特殊津贴。邮箱:yilong528@aliyun.com。
    目前担任首都医科大学附属北京天坛医院院长助理、科研处处长、神经病学中心临床试验与临床研究中心主任、首都医科大学五系循证医学教研室主任。中国卒中学会第一届青年理事会执行理事长、中华医学会临床流行病学分会委员、方法学组副组长、中华医学会神经病学分会青年委员、北京医学会神经病学分会第一届青年委员会副主任委员、卫生部国家脑卒中质控中心秘书长、世界卒中协会理事、北京脑血管病防治协会副秘书长、国家神经系统疾病临床医学研究中心办公室主任。荣获教育部长江学者青年长江奖励计划、国家自然基金委员会优秀青年基金、教育部新世纪优秀人才、北京市科技新星、北京市高层次卫生专业技术人才等奖励。曾在美国加州大学旧金山医学院(UCSF)读博士后。目前主要围绕缺血性小卒中与短暂性脑缺血发作(TIA)的危险因素研究方面开展了系列研究。科技部“十二五”国家支撑计划重大专项之脑血管病急性期诊疗技术规范化应用和医疗质量评价与持续改进技术研究负责人。《中国实用内科杂志》、《中国卒中杂志》等核心期刊杂志编委,参加多部专著编写,以第一作者在Circulation、Neurology、Stroke等专业杂志发表SCI论文29篇,累计影响因子136分,共同作者发表SCI文章100余篇,累计影响因子300余分。
 
代表性论文:
1、Wang Y., Wang Y., Zhao X., Liu L., Wang D., Wang C., Wang C., Li H., Meng X., Cui L., Jia J., Dong Q., Xu A., Zeng J., Li Y., Wang Z., Xia H., Johnston S. C., the Chance Investigators. N Engl J Med ,Clopidogrel with aspirin in acute minor stroke or transient ischemic attack ,2013;, 369(1): 11-19.
2、Wong K. S. L., Wang Y., Leng X., Mao C., Tang J., Bath P. M. W., Markus H. S., Gorelick P. B., Liu L., Lin W., Wang Y. Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: An updated systematic review and meta-analysis ,Circulation,2013; 128(15): 1656-1666.
3、Yilong Wang, Yuesong Pan, Xingquan Zhao,et al. Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) One-Year Outcomes.Circulation. 2015 Jul 7;132(1):40-6.
 
研究方向:
1、脑血管病医疗服务质量监测与改进研究;
2、TIA和小卒中流行病学、预后与标记物研究;
3、基于多模式影像学指导急性缺血性卒中血管再灌注治疗策略研究
所获奖项和荣誉:
1、缺血性脑血管病医疗质量评价与防治优化体系的建立和临床应用   北京市科技进步奖         一等奖  
2、缺血性脑血管病复发风险评估与防治优化新策略的研究           教育部高等学校科学技术奖 一等奖 
3、动脉粥样硬化性脑血管病的流行病学与防治的研究              中华预防医学会科学技术奖 一等奖
 
发表论文:
1 Lin J, Zheng H, Cucchiara BL, Li J, Zhao X, Liang X, Wang C, Li H, Mullen MT, Johnston SC, Wang Y, Wang Y; CHANCE investigators.Association of Lp-PLA2-A and early recurrence of vascular events following
TIA and minor stroke.Neurology. 2015 Nov 3;85(18):1585-91."
2 Xianwei Wang,yilong Wang,et al.Effect of clopidogrel with aspirin on functional outcome in TIA or minor stroke. ,Neurology. 2015 Aug 18;85(7):573-9. 
3 Yilong Wang, Yuesong Pan, Xingquan Zhao,et al. Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) One-Year Outcomes.Circulation. 2015 Jul 7;132(1):40-6.
4 Li J, Wang Y, Lin J, Wang D, Wang A, Zhao X, Liu L, Wang C, Wang Y; CHANCE Investigators.Soluble CD40L Is a Useful Marker to Predict FutureStrokes in Patients With Minor Stroke and Transient Ischemic Attack.Stroke. 2015 Jul;46(7):1990-2
5 Yilong Wang,Zixiao.et al. Rationale and design of a cluster-randomized multifaceted intervention trial to improve stroke care quality in China: The GOLDEN BRIDGE–Acute Ischemic Stroke.Am Heart J. 2015 Jun;169(6):767-774
6 Yilong Wang, Xingquan Zhao,et al. Yong Jiang,Prevalence, knowledge, and treatment of transient ischemic attacks in China.Neurology. 2015 Jun 9;84(23):2354-61
7 Chen W, Pan Y, Zhao X, et al. Totaled health risks in vascular events score predicts clinical outcome and symptomatic intracranial hemorrhage in Chinese patients after thrombolysis. Stroke. 2015 Mar;46(3):864-6
8 Li J, Wang Y, Wang D, Lin J, Wang A, Zhao X, Liu L, Wang C, Wang Y.Glycated Albumin Predicts the Effect of Dual and Single Antiplatelet Therapy on Recurrent Stroke.Neurology. 2015 Mar 31;84(13):1330-6
9 Pan Y, Chen Q, Zhao X, Liao X, Wang C, Du W, Liu G, Liu L, Wang C, Wang Y, Wang Y. Cost-Effectiveness of Thrombolysis Within 4.5 Hours of Acute Ischemic Stroke in China.PLoS One. 2014 Oct 20;9(10):e110525.
10 Wang Y L, Pan Y S, Zhao X Q, et al. Recurrent Stroke was Associated with Poor Quality of Life in Patients with Transient Ischemic Attack or Minor Stroke: Finding from the CHANCE Trial[J]. CNS Neuroscience & Therapeutics, 2014.20(12):1029-35
11 Pan Y, Chen Q, Liao X, et al. Preexisting dual antiplatelet treatment increases the risk of post-thrombolysis intracranial hemorrhage in Chinese stroke patients[J]. Neurological research, 2014;37(1):64-8
12 Pan Y, Jing J, Zhang R, et al. Poor Performance of Stroke Prognostication using Age and National Institutes of Health Stroke Scale-100 to Predict 3-and 12-month Outcomes of Ischemic Stroke in China National Stroke Registry[J]. Journal of Stroke and Cerebrovascular Diseases, 2014.23(9):2335-40
13 Pan Y, Wang A, Liu G, et al. Cost‐Effectiveness of Clopidogrel‐Aspirin Versus Aspirin Alone for Acute Transient Ischemic Attack and Minor Stroke[J]. Journal of the American Heart Association, 2014, 3(3): e000912.
14 Wang Y, Miao Z, Wang Y, et al. Protocol for a prospective, multicentre registry study of stenting for symptomatic intracranial artery stenosis in China[J]. BMJ open, 2014, 4(8): e005175.
15 Luo Y, Wang X, Matsushita K, et al. Associations Between Estimated Glomerular Filtration Rate and Stroke Outcomes in Diabetic Versus Nondiabetic Patients[J]. Stroke, 2014, 45(10): 2887-2893.
16 Zhang C, Wang Y, Zhao X, et al. Distal Single Subcortical Infarction Had a Better Clinical Outcome Compared With Proximal Single Subcortical Infarction[J]. Stroke, 2014, 45(9): 2613-2619.
17 Wang X, Wang Y, Wang C, et al. Association between estimated glomerular filtration rate and clinical outcomes in patients with acute ischaemic stroke: results from China National Stroke Registry[J]. Age and ageing, 2014: afu090.
18 Song B, Wang Y, Zhao X, et al. Association between Statin Use and Short-Term Outcome Based on Severity of Ischemic Stroke: A Cohort Study[J]. PloS one, 2014, 9(1): e84389.
19 Wang Y, Xu J, Zhao X, et al. Association of hypertension with stroke recurrence depends on ischemic stroke subtype[J]. Stroke, 2013, 44(5): 1232-1237.
20 Zheng H W, Wang Y L, Lin J X, et al. Circulating MicroRNAs as potential risk biomarkers for hematoma enlargement after intracerebral hemorrhage[J]. CNS neuroscience & therapeutics, 2012, 18(12): 1003-1011.
21 Deng Y X, Wang Y L, Gao B Q, et al. Age differences in clinical characteristics, health care, and outcomes after ischemic stroke in China[J]. CNS neuroscience & therapeutics, 2012, 18(10): 819-826.
22 Meng X, Wang Y, Zhao X, et al. Validation of the essen stroke risk score and the stroke prognosis instrument II in Chinese patients[J]. Stroke, 2011, 42(12): 3619-3620.
23 Wang Y, Liao X, Zhao X, et al. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in china analysis of the results from the Chinese National Stroke Registry (CNSR)[J]. Stroke, 2011, 42(6): 1658-1664.
24 Li N, Wang Y, Wang W, et al. Contrast Extravasation on Computed Tomography Angiography Predicts Clinical Outcome in Primary Intracerebral Hemorrhage A Prospective Study of 139 Cases[J]. Stroke, 2011, 42(12): 3441-3446.
25 Wang Y L, Wu D, Nguyen‐Huynh M N, et al. Antithrombotic management of ischaemic stroke and transient ischaemic attack in China: A consecutive cross‐sectional survey[J]. Clinical and Experimental Pharmacology and Physiology, 2010, 37(8): 775-781.
26 Wang Y, Wu D, Zhao X, et al. Hospital resources for urokinase/recombinant tissue-type plasminogen activator therapy for acute stroke in Beijing[J]. Surgical neurology, 2009, 72: S2-S7.
27 Wang Y, Liao X, Zhao X, et al. Imaging‐based thrombolysis trial in acute ischemic stroke‐II (ITAIS‐II)[J]. International Journal of Stroke, 2009, 4(1): 49-53.
28 Wang Y, Wu D, Zhou Y, et al. Survey of blood pressure control status in patients with ischemic stroke or transient ischemic attack in China[J]. Neurological Research, 2008, 30(4): 348-355.
29 Wang Y L, Wu D, Liao X, et al. Burden of stroke in China[J]. International Journal of Stroke, 2007, 2(3): 211-213.
 

友情链接

地 址:北京市丰台区右安门外西头条10号

邮 编:100069

邮 箱:BIBD@CCMU.EDU.CN

总访问量:00001251.LA QUEOTE

京公网安备1104024300022号